DRxChoice Fiber Capsules — Class II drug recall D-032-2013
Terminated recall by Raritan Pharmaceuticals, Inc., reported 2012-10-31, distributed nationwide. Microbial Contamination of Non-Sterile Products: Product is being recalled due to possible microbial contamina
| Recall number | D-032-2013 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Raritan Pharmaceuticals, Inc., East Brunswick, NJ, United States |
| Recall initiated | 2012-09-04 |
| Classified | 2012-10-25 |
| Reported by FDA | 2012-10-31 |
| Terminated | 2014-10-07 |
| Distributed | Nationwide (US) |
| Quantity | 17,136 bottles |
| Reason classes | microbial contamination, sterility |
| UPC / GTIN / UDI-DI | 00368163119251 |
| Lot numbers | 06/15, 08/15, 16274, 16471 |
Product
DRxChoice Fiber Capsules, 25 capsules per bottle, Psyllium Husk Fiber, Mfg. by Raritan Pharmaceuticals, East Brunswick, NJ, UPC 3-68163-11925-1.
Reason for recall
Microbial Contamination of Non-Sterile Products: Product is being recalled due to possible microbial contamination by C. difficile discovered in the raw material.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-032-2013. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.